- Home
- SXTC vs CIIT Comparison
SXTC vs CIIT Comparison
Compare SXTC & CIIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- CIIT
- Stock Information
- Founded
- SXTC 2005
- CIIT N/A
- Country
- SXTC China
- CIIT Hong Kong
- Employees
- SXTC N/A
- CIIT N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- CIIT
- Sector
- SXTC Health Care
- CIIT
- Exchange
- SXTC Nasdaq
- CIIT NYSE
- Market Cap
- SXTC 34.4M
- CIIT 34.6M
- IPO Year
- SXTC 2019
- CIIT N/A
- Fundamental
- Price
- SXTC $1.85
- CIIT $2.18
- Analyst Decision
- SXTC
- CIIT
- Analyst Count
- SXTC 0
- CIIT 0
- Target Price
- SXTC N/A
- CIIT N/A
- AVG Volume (30 Days)
- SXTC 726.7K
- CIIT 118.8K
- Earning Date
- SXTC 01-01-0001
- CIIT 06-09-2025
- Dividend Yield
- SXTC N/A
- CIIT N/A
- EPS Growth
- SXTC N/A
- CIIT N/A
- EPS
- SXTC 20.77
- CIIT N/A
- Revenue
- SXTC $1,818,404.00
- CIIT $9,464,501.00
- Revenue This Year
- SXTC N/A
- CIIT N/A
- Revenue Next Year
- SXTC N/A
- CIIT N/A
- P/E Ratio
- SXTC $0.09
- CIIT N/A
- Revenue Growth
- SXTC 6.78
- CIIT 51.52
- 52 Week Low
- SXTC $0.95
- CIIT $1.30
- 52 Week High
- SXTC $11.92
- CIIT $5.38
- Technical
- Relative Strength Index (RSI)
- SXTC 51.80
- CIIT N/A
- Support Level
- SXTC $1.84
- CIIT N/A
- Resistance Level
- SXTC $1.95
- CIIT N/A
- Average True Range (ATR)
- SXTC 0.29
- CIIT 0.00
- MACD
- SXTC 0.04
- CIIT 0.00
- Stochastic Oscillator
- SXTC 62.50
- CIIT 0.00
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About CIIT TIANCI INTERNATIONAL INC
Tianci International Inc along with its subsidiaries is engaged in sale of components of electronic devices, development of software and websites, technical consulting, and providing maintenance support on customized software. The company's business is predominantly carried out in Hong Kong with a substantial portion of its overall revenue being generated from its Electronic Device Hardware Components Sales segment.